{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:33:01Z","timestamp":1789144381521,"version":"build-2803163510"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Heart Lung, and Blood Institute of the National Institutes of Health","award":["HL115575 and HL117724"],"award-info":[{"award-number":["HL115575 and HL117724"]}]},{"name":"American Heart Association to MVA","award":["13GRNT1685003"],"award-info":[{"award-number":["13GRNT1685003"]}]},{"name":"American Heart Association pre-doctoral fellowship","award":["16PRE31220005"],"award-info":[{"award-number":["16PRE31220005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cyto.2017.09.031","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T09:54:04Z","timestamp":1512554044000},"page":"154175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Regulation of pro- and anti-atherogenic cytokines"],"prefix":"10.1016","volume":"122","author":[{"given":"Mitali","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Autieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0005","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cyto.2017.09.031_b0015","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0891-5849(00)00227-6","article-title":"Regulation of cell growth by oxidized LDL","volume":"28","author":"Chisolm","year":"2000","journal-title":"Free Radical Biol. Med."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1073\/pnas.82.2.416","article-title":"Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages","volume":"82","author":"Tabas","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00011-009-0052-4","article-title":"Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation","volume":"58","author":"Ye","year":"2009","journal-title":"Inflamm. Res."},{"issue":"22","key":"10.1016\/j.cyto.2017.09.031_b0030","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/CIRCULATIONAHA.111.051599","article-title":"Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses","volume":"124","author":"Ketelhuth","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0035","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.110.973222","article-title":"Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice","volume":"123","author":"Hermansson","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cyto.2017.09.031_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/joim.12589","article-title":"Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis","volume":"281","author":"Gistera","year":"2017","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0045","first-page":"332","article-title":"Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses","volume":"112","author":"Assinger","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0050","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI119813","article-title":"Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions","volume":"100","author":"Napoli","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.031_b0055","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","article-title":"A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. a report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association","volume":"89","author":"Stary","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.micron.2005.10.007","article-title":"Monocyte recruitment and foam cell formation in atherosclerosis","volume":"37","author":"Bobryshev","year":"2006","journal-title":"Micron"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0065","doi-asserted-by":"crossref","first-page":"e000117","DOI":"10.1161\/JAHA.113.000117","article-title":"T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: the multi-ethnic study of atherosclerosis","volume":"2","author":"Tracy","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0070","first-page":"359","article-title":"Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice","volume":"149","author":"Zhou","year":"1996","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.cyto.2017.09.031_b0075","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1371\/journal.pone.0000779","article-title":"Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions","volume":"2","author":"de Boer","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.031_b0085","first-page":"200","article-title":"The role of lysosomes in cellular pathology","volume":"9","author":"De Duve","year":"1970","journal-title":"Triangle"},{"issue":"13","key":"10.1016\/j.cyto.2017.09.031_b0090","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0095","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey","volume":"119","author":"Aggarwal","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2017.09.031_b0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/euhj.2001.2805","article-title":"Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men","volume":"23","author":"Skoog","year":"2002","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.108.180273","article-title":"Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation","volume":"103","author":"Woollard","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-3083.1999.00559.x","article-title":"Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice","volume":"50","author":"Zhou","year":"1999","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-alpha signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukar. Gene Expr."},{"issue":"13","key":"10.1016\/j.cyto.2017.09.031_b0125","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1074\/jbc.271.13.7767","article-title":"Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated","volume":"271","author":"Hsu","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.cyto.2017.09.031_b0130","doi-asserted-by":"crossref","first-page":"41035","DOI":"10.1074\/jbc.M003464200","article-title":"Tumor necrosis factor-alpha -mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2017.09.031_b0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1749-6632.1994.tb17348.x","article-title":"Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions","volume":"748","author":"Galis","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1657526","article-title":"Tissue factor in the pathogenesis of atherosclerosis","volume":"78","author":"Taubman","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0145","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice","volume":"24","author":"Branen","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2003.10.004","article-title":"Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus","volume":"172","author":"Canault","year":"2004","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"Taylor","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0160","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2017.09.031_b0165","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0021-9150(94)05503-B","article-title":"Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells","volume":"115","author":"Wang","year":"1995","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(03)00284-3","article-title":"Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis","volume":"170","author":"Kaden","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2017.09.031_b0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.vph.2015.04.013","article-title":"IL-1beta enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release","volume":"72","author":"Eun","year":"2015","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2006.11.026","article-title":"Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism","volume":"195","author":"Kamari","year":"2007","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.143.1.15","article-title":"Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma","volume":"143","author":"Gajewski","year":"1989","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000331970405500308","article-title":"Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice","volume":"55","author":"Upadhya","year":"2004","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2011.09.050","article-title":"Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells","volume":"220","author":"Dietrich","year":"2012","journal-title":"Atherosclerosis"},{"issue":"47","key":"10.1016\/j.cyto.2017.09.031_b0210","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0225","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"22","key":"10.1016\/j.cyto.2017.09.031_b0230","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/intimm\/dxt043","article-title":"T cells in atherosclerosis","volume":"25","author":"Tse","year":"2013","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.031_b0240","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0245","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0250","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0255","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0265","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0270","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0275","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(-\/-) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.031_b0280","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/ard.2008.097089","article-title":"Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus","volume":"68","author":"Cheng","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.031_b0285","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2011.10.093","article-title":"Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque","volume":"154","author":"Xia","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0295","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.atherosclerosis.2015.08.006","article-title":"IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice","volume":"242","author":"Rattik","year":"2015","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","article-title":"Interleukin-23: a key cytokine in inflammatory diseases","volume":"43","author":"Duvallet","year":"2011","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0305","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/STROKEAHA.114.006516","article-title":"Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23\/interleukin 17 axis","volume":"46","author":"Abbas","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cytogfr.2008.11.003","article-title":"Interferon gamma: a master regulator of atherosclerosis","volume":"20","author":"McLaren","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.031_b0315","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.mol.0000182532.11512.90","article-title":"Regulatory T cell responses: potential role in the control of atherosclerosis","volume":"16","author":"Mallat","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0320","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00011-005-1377-2","article-title":"Gamma interferon: a central mediator in atherosclerosis","volume":"54","author":"Leon","year":"2005","journal-title":"Inflamm. Res."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0325","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.031_b0330","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-\/- mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.031_b0335","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2353\/ajpath.2008.070776","article-title":"Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis","volume":"172","author":"Schulte","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0345","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/ATVBAHA.112.300871","article-title":"T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke","volume":"33","author":"Engelbertsen","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/pr.55.1.5","article-title":"Interleukins in atherosclerosis: molecular pathways and therapeutic potential","volume":"55","author":"von der Thusen","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.cyto.2017.09.031_b0355","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0360","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors","volume":"145","author":"Swain","year":"1990","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0365","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0370","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0375","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/intimm\/dxh050","article-title":"IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms","volume":"16","author":"Wurtz","year":"2004","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.031_b0380","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2017.09.031_b0385","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0390","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","article-title":"IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR","volume":"104","author":"Krishnamurthy","year":"2009","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.cyto.2017.09.031_b0395","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1096\/fj.01-0483fje","article-title":"Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-\/- mice","volume":"15","author":"Von Der Thusen","year":"2001","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2017.09.031_b0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0405","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2005.10.029","article-title":"Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10","volume":"188","author":"Liu","year":"2006","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.cyto.2017.09.031_b0410","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/sj.gt.3302348","article-title":"Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice","volume":"11","author":"Yoshioka","year":"2004","journal-title":"Gene Ther."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0415","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.4049\/jimmunol.173.11.6712","article-title":"IL-19 induced Th2 cytokines and was up-regulated in asthma patients","volume":"173","author":"Liao","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0420","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2353\/ajpath.2008.080163","article-title":"Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia","volume":"173","author":"Tian","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0425","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/ATVBAHA.110.214916","article-title":"The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells","volume":"31","author":"Jain","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0430","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/ATVBAHA.113.301521","article-title":"Attenuation of experimental atherosclerosis by interleukin-19","volume":"33","author":"Ellison","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.031_b0435","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajpath.2015.12.023","article-title":"IL-19 halts progression of atherosclerotic plaque, polarizes, and increases cholesterol uptake and efflux in macrophages","volume":"186","author":"Gabunia","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0440","doi-asserted-by":"crossref","first-page":"C255","DOI":"10.1152\/ajpcell.00069.2013","article-title":"Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability","volume":"305","author":"England","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.031_b0445","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.yjmcc.2010.04.016","article-title":"Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability","volume":"49","author":"Cuneo","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.031_b0450","doi-asserted-by":"crossref","first-page":"C896","DOI":"10.1152\/ajpcell.00439.2010","article-title":"Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility","volume":"300","author":"Gabunia","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0455","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0460","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0465","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","article-title":"IL-33 reduces macrophage foam cell formation","volume":"185","author":"McLaren","year":"2010","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2017.09.031_b0470","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1182\/blood-2003-05-1729","article-title":"Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice","volume":"102","author":"Gojova","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cyto.2017.09.031_b0475","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/hh2201.099415","article-title":"Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0480","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm0195-74","article-title":"The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.cyto.2017.09.031_b0485","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.90.21.10193","article-title":"Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8","volume":"90","author":"Matsusaka","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0490","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","article-title":"STATs: signal transducers and activators of transcription","volume":"84","author":"Ihle","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cyto.2017.09.031_b0495","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2017.09.031_b0500","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2007.01.002","article-title":"Modulation of mRNA stability as a novel therapeutic approach","volume":"114","author":"Eberhardt","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.031_b0505","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1073\/pnas.83.6.1670","article-title":"Identification of a common nucleotide sequence in the 3\u2032-untranslated region of mRNA molecules specifying inflammatory mediators","volume":"83","author":"Caput","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.cyto.2017.09.031_b0510","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.156.8.3043","article-title":"Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3\u2032-untranslated region in the genetic predisposition to lupus-like autoimmune disease","volume":"156","author":"Jacob","year":"1996","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0515","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0520","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0022034512437372","article-title":"Control of cytokine mRNA expression by RNA-binding proteins and microRNAs","volume":"91","author":"Palanisamy","year":"2012","journal-title":"J. Dent. Res."},{"issue":"11","key":"10.1016\/j.cyto.2017.09.031_b0525","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1074\/jbc.273.11.6417","article-title":"Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR","volume":"273","author":"Levy","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0530","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/MCB.21.3.721-730.2001","article-title":"The 3\u2032 untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR","volume":"21","author":"Dean","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2017.09.031_b0535","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(00)80411-2","article-title":"A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency","volume":"4","author":"Taylor","year":"1996","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0540","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/wrna.26","article-title":"The role of AUF1 in regulated mRNA decay","volume":"1","author":"Gratacos","year":"2010","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"15","key":"10.1016\/j.cyto.2017.09.031_b0545","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1093\/emboj\/19.15.4154","article-title":"TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha","volume":"19","author":"Piecyk","year":"2000","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.cyto.2017.09.031_b0550","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1083\/jcb.147.7.1431","article-title":"RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules","volume":"147","author":"Kedersha","year":"1999","journal-title":"J. Cell. Biol."},{"issue":"22","key":"10.1016\/j.cyto.2017.09.031_b0555","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","article-title":"Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy","volume":"24","author":"Timchenko","year":"1996","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.cyto.2017.09.031_b0560","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1261\/rna.59606","article-title":"CUG-BP binds to RNA substrates and recruits PARN deadenylase","volume":"12","author":"Moraes","year":"2006","journal-title":"RNA"},{"issue":"33","key":"10.1016\/j.cyto.2017.09.031_b0565","doi-asserted-by":"crossref","first-page":"22457","DOI":"10.1074\/jbc.M802803200","article-title":"The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy","volume":"283","author":"Zhang","year":"2008","journal-title":"J .Biol. Chem."},{"issue":"12","key":"10.1016\/j.cyto.2017.09.031_b0570","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1128\/MCB.18.12.6879","article-title":"Embryo deadenylation element-dependent deadenylation is enhanced by a cis element containing AUU repeats","volume":"18","author":"Audic","year":"1998","journal-title":"Mol. Cell. Biol."},{"issue":"18","key":"10.1016\/j.cyto.2017.09.031_b0575","first-page":"1380","article-title":"Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease","volume":"38","author":"de Bruin","year":"2017","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cyto.2017.09.031_b0580","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2013.04.016","article-title":"Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs","volume":"153","author":"Leppek","year":"2013","journal-title":"Cell"},{"issue":"Pt 8","key":"10.1016\/j.cyto.2017.09.031_b0585","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1107\/S2053230X15011887","article-title":"Structure of human Roquin-2 and its complex with constitutive-decay element RNA","volume":"71","author":"Sakurai","year":"2015","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"10.1016\/j.cyto.2017.09.031_b0590","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1038\/ncomms10846","article-title":"Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression","volume":"7","author":"de Bruin","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.cyto.2017.09.031_b0595","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/CIRCRESAHA.113.301302","article-title":"Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype","volume":"113","author":"van der Veer","year":"2013","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.cyto.2017.09.031_b0600","doi-asserted-by":"crossref","first-page":"22819","DOI":"10.1074\/jbc.M501106200","article-title":"Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR","volume":"280","author":"Pullmann","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cyto.2017.09.031_b0605","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/gene.10060","article-title":"Quaking is essential for blood vessel development","volume":"32","author":"Noveroske","year":"2002","journal-title":"Genesis"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T18:15:06Z","timestamp":1693332906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617302892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":121,"alternative-id":["S1043466617302892"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.09.031","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of pro- and anti-atherogenic cytokines","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154175"}}